Showing posts with label vapor. Show all posts
Showing posts with label vapor. Show all posts

Monday, February 19, 2018

American Cancer Society Releases Position Statement on E-Cigs

The American Cancer Society just released the below position statement on e-cigs. This is a HUGE step forward in our fight to prove how much less harmful Vaping is than smoking! 
You can view the original statement HERE.

============

"American Cancer Society Position Statement on Electronic Cigarettes
The American Cancer Society Board of Directors approved the following position statement on electronic cigarettes (e-cigarettes) in February 2018. The position statement will be used to guide ACS’s tobacco control and cessation efforts as it relates to these products.

ACS Position Statement on Electronic Cigarettes
Combustible tobacco products, primarily cigarettes, are the single greatest cause of cancer and kill about 7 million people worldwide each year.  In the United States, 98% of all tobacco-related deaths are caused by cigarette smoking.  The U.S. tobacco landscape has changed rapidly in recent years, with millions of consumers now using electronic nicotine delivery systems (ENDS), the most prominent of which are electronic cigarettes (e-cigarettes).  E-cigarettes contain heated nicotine extracted from tobacco, as well as a variety of flavorings and other additives.

Scientific Summary: Based on currently available evidence, using current generation e-cigarettes is less harmful than smoking cigarettes, but the health effects of long-term use are not known.  The American Cancer Society (the ACS) recognizes our responsibility to closely monitor and synthesize scientific knowledge about the effects of all tobacco products, including e-cigarettes and any new products derived from tobacco.  As new evidence emerges, the ACS will promptly report these findings to policy makers, the public and clinicians.  

Clinical Recommendations: The ACS has always supported any smoker who is considering quitting, no matter what approach they use; there is nothing more important that they can do for their health.  To help smokers quit, the ACS recommends that clinicians advise their patients to use FDA-approved cessation aids that have been proven to support successful quit attempts. Many smokers choose to quit smoking without the assistance of a clinician and some opt to use e-cigarettes to accomplish this goal. The ACS recommends that clinicians support all attempts to quit the use of combustible tobacco and work with smokers to eventually stop using any tobacco product, including e-cigarettes.  Some smokers, despite firm clinician advice, will not attempt to quit smoking cigarettes and will not use FDA approved cessation mediations.  These individuals should be encouraged to switch to the least harmful form of tobacco product possible; switching to the exclusive use of e-cigarettes is preferable to continuing to smoke combustible products.  Of course, these individuals should be regularly advised to completely quit using all tobacco products.  The ACS strongly discourages the concurrent (or “dual”) use of e-cigarettes and combustible cigarettes, a behavior that is far more detrimental to a person’s health compared to the substantial health benefit of quitting smoking.

Policy Recommendations: The American Cancer Society recommends implementing polices and public health measures known to prevent the initiation and use of all tobacco products, including appropriate taxation, retail policies (e.g., raising the minimum age of purchase to 21), tobacco and e-cigarette aerosol-free policies and funding of evidence-based prevention and cessation programs.  The ACS strongly recommends that every effort be made to prevent the initiation of e-cigarettes by youth.  The use of products containing nicotine in any form among youth is unsafe and can harm brain development. Furthermore, evidence indicates that young e-cigarette users are at increased risk for both starting to smoke and becoming long-term users of combustible tobacco products.

The ACS encourages the FDA to regulate all tobacco products, including e-cigarettes, to the full extent of its authority, and to determine the absolute and relative harms of each product.  The FDA should assess whether e-cigarettes help to reduce tobacco-related morbidity and mortality, and the impact of marketing of e-cigarettes on consumer perceptions and behavior.  Any related regulatory regime should include post-marketing surveillance to monitor the long-term effects of these products and ensure the FDA’s actions have the intended health outcome of significantly reducing disease and death.  Furthermore, the FDA should use its authorities to reduce the toxicity, addictiveness and appeal of tobacco products currently on the market.  The ACS also applauds the FDA for recognizing its significant role as a science-based agency in helping to address the addictiveness of nicotine in cigarettes.  Reducing nicotine in all combustible tobacco products to below addictive levels holds the potential to significantly accelerate reductions in the use of combustible tobacco products, which remain by far the leading preventable cause of cancer and preventable death in the United States."


============

For up to date information follow The American Cancer Society online:

Monday, November 20, 2017

New Vaping Study Shows No Harm

Contact: Gregory Conley
Tel: 609-947-8059
Email: gconley@vaping.org
FOR IMMEDIATE RELEASE
November 20, 2017 at 9:30 AM

Landmark Long-Term Study on Vaping by Never-Smokers Finds No Negative Health Impacts


Despite fears of activists, no harm seen after three and a half years of vaping
LONDON, ENGLAND -- In a first of its kind long-term study published in the journal Nature, researchers have found no negative health impacts from the daily use of electronic cigarettes by young adult never-smokers.

Researchers from the University of Catania, led by Dr. Riccardo Polosa, tracked nine electronic cigarette users with no history of smoking, as well as twelve lifetime non-smokers and non-vapers, over the course of three and a half years. The researchers found no impact on a variety of health outcomes, including blood pressure, heart rate, lung function, exhaled breath nitric oxide, exhaled carbon monoxide, and CT scans of the lungs. 

“In spite of previous health scares, our study shows for the first time no risk in long-term vapers who have never smoked in their life,” said Polosa, who presented the study at the fifth annual E-Cigarette Summit in the United Kingdom on Friday, November 17th.

Polosa notes that while even longer-term research is needed to rule out any possible negative impacts, changes in spirometry and CT scans can be seen in young smokers after approximately two years of cigarette usage. With the vapers, no signs of lung damage, including COPD, lipoid pneumonia, and popcorn lung, were found in CT scans, even among the study participants with the highest consumption of e-liquid.

In the United States, far less than 1% of adult never-smokers are current vapers, with an even smaller proportion reporting vaping daily, according to the CDC’s 2015 National Health Interview Survey. Despite this, much of the concern in the media and scientific circles revolve around fears of the impact of vaping on nonsmokers. 

“Mouse and cell studies may generate salacious headlines about the supposed dangers of vaping, but they are no replacement for studies on actual humans,” said Gregory Conley, President of the American Vaping Association, a nonprofit that advocates for truthful information about vapor products. “If no negative health impacts can be seen from daily vaping among those who previously did not smoke, how is it ethical to continue warning smokers away from using these products?” 

In addition to this groundbreaking research, Polosa also recently published a review of the evidence on the impact of vapor products on COPD patients.
# # #
About the American Vaping Association

The American Vaping Association is a nonprofit organization that advocates for policies that encourage the growth and sustainability of small- and medium-sized businesses in the rapidly growing vaping and electronic cigarette industry. The AVA was founded by Gregory Conley, a consumer and industry advocate with a long track record of advocating for vapor products dating back to 2010.

We are dedicated to educating the public and government officials about public health benefits offered by vapor products, which are battery-powered devices that heat a liquid nicotine or nicotine-free solution and create an inhalable vapor.  The AVA is not a trade group and does not speak for any particular businesses, including our industry sponsors.

You can learn more about AVA and vaping by visiting the AVA website. You can also find us on Facebook, Twitter, and Instagram.



Tuesday, October 3, 2017

Vaping Could Save 6.6 Million American Smokers


Contact: Gregory Conley
Tel: 609-947-8059
Email: gconley@vaping.org
FOR IMMEDIATE RELEASE
October 3, 2017 at 9:00 AM

Major U.S. Study: Vaping Could Save 6.6 Million American Smokers


Even under worse case assumptions, vaping still saves lives, finds multi-university research study
WASHINGTON, D.C. -- In what could turn out to be a transformative moment in the debate over vaping in America, a research team led by investigators from Georgetown Lombardi Comprehensive Cancer Center is now estimating that vaping could save the lives of up to 6.6 million U.S. smokers over the next 10 years. On the basis of this evidence, the researchers are recommending that public health organizations adopt a strategy of encouraging smokers to switch to vaping to hasten the decline of America’s smoking rate.
Published in the journal Tobacco Control, the study is the first to model the best and worst case outcomes of U.S. smokers switching to vaping. In establishing their variables, the researchers considered a range of factors, including differing estimates on the relative harm of vapor products versus cigarettes, as well as the impact of vaping on cessation, switching, and initiation, including by nonusers.
In the most pessimistic scenario tested by the researchers, a strategy of replacing cigarettes with vaping is calculated to save 1.6 million lives, or 160,000 lives per year. (Read Reuters' report on the study).
"Even the gloomiest analysis shows a significant gain in years of life if nicotine is obtained from vaping instead of much more deadly amount of toxicants inhaled with cigarette smoke," said David Levy, a lead researcher and professor of oncology at Georgetown Lombardi. "Old policies need to be supplemented with policies that encourage substituting e-cigarettes for the far more deadly cigarettes."
The study, which involved researchers from Georgetown University, Yale University, the Roswell Park Cancer Institute, and others, was funded by the National Institutes of Health. In total, the researchers conclude that as many as 86.7 million years of life could be gained by smokers who make the switch during the ten year period modeled in the study.
Gregory Conley, President of the American Vaping Association, a nonprofit that champions vaping for smokers looking to quit, commented on the implications of the study:
“This study could represent a seismic shift in the way the FDA and public health groups look at vaping. For years, harm reduction advocates have relied on quality research from independent European researchers and non-government organizations, only to be told that such research was somehow not trustworthy because the authors were not American. Now, we have some of the most respected American researchers in the field of tobacco control explaining in detail how vaping can and will save lives.”
“If there is a fault with this research, it is that it assumes that a functional vaping market will still exist in a decade. Unless FDA Commissioner Scott Gottlieb acts to reform the FDA’s outdated tobacco regulatory system, over 99% of vapor products could be banned in or before 2022. We are hopeful that studies like this will give Gottlieb the confidence he needs to truly modernize the way FDA regulates smoke-free nicotine products."
Other research highlights from this week: 
  • Banning e-cigarette flavors, with or without a corresponding ban on menthol cigarettes, could harm public health by discouraging adult smokers from quitting. That is according to research conducted by the Yale School of Public Health and the Centre for Health Policy at the Imperial College in London, the results of which are being distributed the National Bureau of Economic Research. (MarketWatch coverage).
  • Among young adults in the Chicago area, e-cigarette use was not associated with later cigarette smoking, according to research published by the journal Addiction.  
# # #
About the American Vaping Association

The American Vaping Association is a nonprofit organization that advocates for policies that encourage the growth and sustainability of small- and medium-sized businesses in the rapidly growing vaping and electronic cigarette industry. The AVA was founded by Gregory Conley, a consumer and industry advocate with a long track record of advocating for vapor products dating back to 2010.

We are dedicated to educating the public and government officials about public health benefits offered by vapor products, which are battery-powered devices that heat a liquid nicotine or nicotine-free solution and create an inhalable vapor.  The AVA is not a trade group and does not speak for any particular businesses, including our industry sponsors.

You can learn more about AVA and vaping by visiting the AVA website. You can also find us on Facebook, Twitter, and Instagram.